Stegent Equity Advisors’s Medpace MEDP Stock Holding History

Stegent Equity Advisors’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-647	Closed	-$203K	–	112
2025 Q2	$203K	Buy	+647	New	+$194K	0.18%	105

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mawer Investment Management Calgary, Alberta, Canada $15.4B AUM 10.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Stegent Equity Advisors's MEDP Position: Q3 2025 in Review

Stegent Equity Advisors sold out of Medpace (MEDP) in Q3 2025, closing a stake of 647 shares — an estimated $203K sold.

Stegent Equity Advisors first reported a position in MEDP in Q2 2025 and held it in 1 quarter. The position peaked at $203K in Q2 2025. 672 funds tracked by Wall St. Rank hold MEDP as of Q3 2025.

Stegent Equity Advisors reported no remaining Medpace position as of Q3 2025 after selling out during the quarter.
Stegent Equity Advisors sold 647 Medpace shares in Q3 2025, an estimated $203K.
Stegent Equity Advisors first reported a position in Medpace in Q2 2025 and held it in 1 quarter.
Stegent Equity Advisors's Medpace position peaked at $203K in Q2 2025.
672 funds tracked by Wall St. Rank held Medpace as of Q3 2025.

Based on Stegent Equity Advisors's 13F filing for Q3 2025, filed 29 Oct 2025.